Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 817-822

  Shaw, Linda A ^a,b   Coker, Susan J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Preclinical Research   (Switzerland)

Author keywords

5 HT2 antagonist; 5 hydroxytryptamine; Arrhythmias; Coronary artery occlusion; ICI 170,809; ICI 192,605; Myocardial ischaemia; Reperfusion; Thromboxane A2; TP antagonist

Indexed keywords

2 [(2 DIMETHYLAMINO 2 METHYLPROPYL)THIO] 3 PHENYLQUINOLINE; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; SEROTONIN 2 ANTAGONIST; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; INCIDENCE; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0029670098     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15266.x     Document Type: Article

References (25)

1. ASHTON, J.H., BENEDICT, C.R., FITZGERALD, C., RAHEJA, S., TAYLOR, A., CAMPBELL, W.B., BUJA, L.M. & WILLERSON, J.T. (1986a). Serotonin is a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation, 73, 572-578.
2. 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Circulation, 76, 952-959.
3. 2 antagonists. Circ. Res., 59, 568-578.
4. BARNES, C.S. & COKER, S.J. (1995). Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia in anaesthetized rats. Br. J. Pharmacol., 114, 349-356.
5. 2 antagonist. FASEB. J., 2, A1404.
6. COKER, S.J. (1984). Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds. J. Mol. Cell. Cardiol., 16, 633-641.
7. COKER, S.J. & ELLIS, A. (1987). Ketanserin and ritanserin can reduce reperfusion-induced arrhythmias but not ischaemia-induced arrhythmias in anaesthetized rats. J. Cardiovasc. Pharmacol., 10, 479-484.
8. COKER, S.J. & PARRATT, J.R (1985). AH23848, a thromboxane antagonist, suppresses ischaemia- and reperfusion-induced arrhythmias in anaesthetized greyhounds. Br. J. Pharmacol., 86, 259-264.
9. COKER, S.J., PARRATT, J.R., LEDINGHAM, I.MCA. & ZEITLIN, I.J. (1981). Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature, 291, 323-324.
10. DE CLERCK, F.F. & HERMAN, A.G. (1983). 5-hydroxytryptamine and platelet aggregation. Fed. Proc., 42, 228-232.
11. DOCHERTY, J.R. (1988). Investigations of cardiovascular 5-HT receptor subtypes in the rat. Naunvn-Schmied. Arch. Pharmacol., 337, 1-8.
12. 2 receptor antagonists on reperfusion-induced arrhythmias in anaesthetized rats. Eur. J. Pharmacol., 219, 97-104.
13. HAEREM, J.W. (1972). Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis, 15, 199-213.
14. 2 receptor antagonist, on platelets. Br. J. Pharmacol., 33, 676P.
15. LEPRAN, I., PARRATT, J.R., SZEKERES, L. & WAINWRIGHT, C. (1985). The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats. Br. J. Pharmacol., 86, 229-234.
16. 2 receptor antagonist (ICI 170,809) on platelet aggregation and pupillary responses in healthy volunteers. Br. J. Clin. Pharmacol., 33, 281-288.
17. MULLANE, K., BRADLEY, G. & MONCADA, S. (1982). The interactions of platelet derived mediators on isolated canine coronary arteries. Eur. J. Pharmacol., 84, 115-118.
18. SAXENA, P.R. & VILLALON, C.M. (1991). 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol. Sci., 12, 223-227.
19. 2 antagonist (ICI 170,809) markedly reduces reperfusion-induced arrhythmias. Br. J. Pharmacol., 107, 126P.
20. 2 and thromboxane antagonists. Br. J. Pharmacol., 112, 479P.
21. SIESS, W. (1989). Molecular mechanisms of platelet activation. Physiol. Rev., 69, 58-178.
22. STEEN, V.M. & HOLMSEN, H. (1987). Current aspects on human platelet activation and responses. Eur. J. Haematol., 38, 383-399.
23. VANDEPLASSCHE, G., HERMANS, C., VAN DAEL, L., WOUTERS, L. & DE CLERCK, F. (1993). Interplay between platelet derived 5-HT and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet rich coronary thrombosis. J. Cardiovasc. Pharmacol., 21, 56-69.
24. WAINWRIGHT, C.L. & PARRATT, J.R. (1985). The effect of β-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischaemia. Adv. Myocardiol., 6, 573-584.
25. WALKER, M.J.A., CURTIS, M.J., HEARSE. D.J., CAMPBELL, R.W.F., JANSE, M.J., YELLON, D.M., COBBE, S.M., COKER, S.J., HARNESS, J.B., HARRON, D.W.G., HIGGINS, A.J., JULIAN, D.G., LAB, M.J., MANNING, A.S., NORTHOVER, B.J., PARRATT, J.R., RIEMERSMA, R.A., RIVA, E., RUSSELL, D.C., SHERIDAN, D.C., WINSLOW, E. & WOOWARD, B. (1988). The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc. Res., 22, 447-455.